Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT): a Phase 2 Randomized, Feasibility Trial

NCT05337618 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT05337618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05337618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT): a Phase 2 Randomized, Feasibility Trial
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Recruiting
Start date
December 16, 2022
Completion date
March 20, 2027
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury